BEAM
Price
$23.44
Change
+$0.04 (+0.17%)
Updated
Jan 17 closing price
Capitalization
1.94B
45 days until earnings call
PYXS
Price
$1.50
Change
+$0.03 (+2.04%)
Updated
Jan 17 closing price
Capitalization
89.2M
61 days until earnings call
Ad is loading...

BEAM vs PYXS

Header iconBEAM vs PYXS Comparison
Open Charts BEAM vs PYXSBanner chart's image
Beam Therapeutics
Price$23.44
Change+$0.04 (+0.17%)
Volume$950.82K
Capitalization1.94B
Pyxis Oncology
Price$1.50
Change+$0.03 (+2.04%)
Volume$776.45K
Capitalization89.2M
BEAM vs PYXS Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. PYXS commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PYXS is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (BEAM: $23.44 vs. PYXS: $1.50)
Brand notoriety: BEAM and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. PYXS: 48%
Market capitalization -- BEAM: $1.94B vs. PYXS: $89.2M
BEAM [@Biotechnology] is valued at $1.94B. PYXS’s [@Biotechnology] market capitalization is $89.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while PYXS’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 6 bearish.
  • PYXS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -11.18% price change this week, while PYXS (@Biotechnology) price change was -3.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was -1.89%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

PYXS is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.94B) has a higher market cap than PYXS($89.2M). PYXS YTD gains are higher at: -3.846 vs. BEAM (-5.484). PYXS has higher annual earnings (EBITDA): -64.04M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. PYXS (145M). PYXS has less debt than BEAM: PYXS (20.5M) vs BEAM (162M). BEAM has higher revenues than PYXS: BEAM (350M) vs PYXS (16.1M).
BEAMPYXSBEAM / PYXS
Capitalization1.94B89.2M2,176%
EBITDA-160.83M-64.04M251%
Gain YTD-5.484-3.846143%
P/E RatioN/AN/A-
Revenue350M16.1M2,174%
Total Cash926M145M639%
Total Debt162M20.5M790%
TECHNICAL ANALYSIS
Technical Analysis
BEAMPYXS
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
80%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
89%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
89%
Aroon
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
89%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.17%
CRSP - BEAM
70%
Closely correlated
+0.57%
NTLA - BEAM
62%
Loosely correlated
+0.85%
DNLI - BEAM
61%
Loosely correlated
+1.20%
PRME - BEAM
60%
Loosely correlated
+0.70%
RXRX - BEAM
59%
Loosely correlated
+2.03%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+2.04%
KURA - PYXS
44%
Loosely correlated
+1.11%
CTMX - PYXS
39%
Loosely correlated
-0.84%
BEAM - PYXS
36%
Loosely correlated
+0.17%
DNLI - PYXS
36%
Loosely correlated
+1.20%
ABOS - PYXS
34%
Loosely correlated
+2.48%
More